|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 301 to 400 out of 454 for Pbsn

<< First    < Previous  |  Next >    Last >>
0.059s

Categories

Hits by Category

Hits by Strain

Type Details Score
Publication
36511483 | J:332199
   
First Author: Germanos AA
Year: 2022
Journal: Elife
Title: Defining cellular population dynamics at single-cell resolution during prostate cancer progression.
Volume: 11
•
•
•
•
•
Publication
22461511 | J:189341
First Author: Zhang Q
Year: 2012
Journal: Cancer Res
Title: Interleukin-17 promotes formation and growth of prostate adenocarcinoma in mouse models.
Volume: 72
Issue: 10
Pages: 2589-99
•
•
•
•
•
Publication
27020859 | J:231906
First Author: Labbé DP
Year: 2016
Journal: Cancer Res
Title: PTP1B Deficiency Enables the Ability of a High-Fat Diet to Drive the Invasive Character of PTEN-Deficient Prostate Cancers.
Volume: 76
Issue: 11
Pages: 3130-5
•
•
•
•
•
Publication
22159221 | J:181111
First Author: Wang S
Year: 2012
Journal: Carcinogenesis
Title: Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer.
Volume: 33
Issue: 2
Pages: 404-12
•
•
•
•
•
Publication
26640144 | J:227989
First Author: Ruscetti M
Year: 2016
Journal: Oncogene
Title: HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer.
Volume: 35
Issue: 29
Pages: 3781-95
•
•
•
•
•
Publication
22069040 | J:180158
First Author: Chen M
Year: 2012
Journal: J Pathol
Title: Loss of epithelial oestrogen receptor α inhibits oestrogen-stimulated prostate proliferation and squamous metaplasia via in vivo tissue selective knockout models.
Volume: 226
Issue: 1
Pages: 17-27
•
•
•
•
•
Publication
30733194 | J:274206
First Author: Wu L
Year: 2019
Journal: Cancer Res
Title: Loss of FOXP3 and TSC1 Accelerates Prostate Cancer Progression through Synergistic Transcriptional and Posttranslational Regulation of c-MYC.
Volume: 79
Issue: 7
Pages: 1413-1425
•
•
•
•
•
Publication
29453322 | J:260731
First Author: Ding M
Year: 2018
Journal: Mol Cancer Res
Title: The mTOR Targets 4E-BP1/2 Restrain Tumor Growth and Promote Hypoxia Tolerance in PTEN-driven Prostate Cancer.
Volume: 16
Issue: 4
Pages: 682-695
•
•
•
•
•
Publication
22505453 | J:184533
First Author: Nacerddine K
Year: 2012
Journal: J Clin Invest
Title: Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer.
Volume: 122
Issue: 5
Pages: 1920-32
•
•
•
•
•
Publication
27869166 | J:241247
First Author: Lu W
Year: 2017
Journal: Oncogene
Title: SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer.
Volume: 36
Issue: 10
Pages: 1364-1373
•
•
•
•
•
Publication
32323921 | J:294705
First Author: Oberhuber M
Year: 2020
Journal: Mol Syst Biol
Title: STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer.
Volume: 16
Issue: 4
Pages: e9247
•
•
•
•
•
Publication
23995785 | J:256658
First Author: Bjerke GA
Year: 2014
Journal: Oncogene
Title: Activation of Akt signaling in prostate induces a TGFβ-mediated restraint on cancer progression and metastasis.
Volume: 33
Issue: 28
Pages: 3660-7
•
•
•
•
•
Publication
24651496 | J:215070
First Author: Bjerke GA
Year: 2014
Journal: PLoS One
Title: Prostate cancer induced by loss of Apc is restrained by TGFβ signaling.
Volume: 9
Issue: 3
Pages: e92800
•
•
•
•
•
Publication
23308238 | J:195893
First Author: Birbach A
Year: 2013
Journal: PLoS One
Title: Use of PB-Cre4 mice for mosaic gene deletion.
Volume: 8
Issue: 1
Pages: e53501
•
•
•
•
•
Publication
35354467 | J:332832
First Author: Limberger T
Year: 2022
Journal: Mol Cancer
Title: KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis.
Volume: 21
Issue: 1
Pages: 89
•
•
•
•
•
Publication
36291720 | J:330701
 
First Author: Wise HM
Year: 2022
Journal: Biomolecules
Title: PTEN Protein Phosphatase Activity Is Not Required for Tumour Suppression in the Mouse Prostate.
Volume: 12
Issue: 10
•
•
•
•
•
Publication
30188869 | J:270445
First Author: Jayaprakash P
Year: 2018
Journal: J Clin Invest
Title: Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy.
Volume: 128
Issue: 11
Pages: 5137-5149
•
•
•
•
•
Publication
28658205 | J:252222
First Author: Zabala-Letona A
Year: 2017
Journal: Nature
Title: mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.
Volume: 547
Issue: 7661
Pages: 109-113
•
•
•
•
•
Publication
28383660 | J:320552
First Author: Shenoy TR
Year: 2017
Journal: Ann Oncol
Title: CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair.
Volume: 28
Issue: 7
Pages: 1495-1507
•
•
•
•
•
Publication
32805234 | J:297483
First Author: Chung WC
Year: 2020
Journal: Am J Pathol
Title: PIK3CG Is a Potential Therapeutic Target in Androgen Receptor-Indifferent Metastatic Prostate Cancer.
Volume: 190
Issue: 11
Pages: 2194-2202
•
•
•
•
•
Publication
29335542 | J:261541
First Author: Chen J
Year: 2018
Journal: Nat Genet
Title: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer.
Volume: 50
Issue: 2
Pages: 219-228
•
•
•
•
•
Publication
24840332 | J:211363
First Author: DeGraff DJ
Year: 2014
Journal: Lab Invest
Title: FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype.
Volume: 94
Issue: 7
Pages: 726-39
•
•
•
•
•
Publication
20679199 | J:163589
First Author: Furic L
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression.
Volume: 107
Issue: 32
Pages: 14134-9
•
•
•
•
•
Publication
21836023 | J:221564
First Author: Kovalenko PL
Year: 2011
Journal: Cancer Prev Res (Phila)
Title: Dietary vitamin D and vitamin D receptor level modulate epithelial cell proliferation and apoptosis in the prostate.
Volume: 4
Issue: 10
Pages: 1617-25
•
•
•
•
•
Publication
37537199 | J:338815
First Author: Ding D
Year: 2023
Journal: Nat Commun
Title: Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis.
Volume: 14
Issue: 1
Pages: 4671
•
•
•
•
•
Publication
28986382 | J:252314
First Author: Yang Y
Year: 2017
Journal: Cancer Res
Title: Loss of FOXO1 Cooperates with TMPRSS2-ERG Overexpression to Promote Prostate Tumorigenesis and Cell Invasion.
Volume: 77
Issue: 23
Pages: 6524-6537
•
•
•
•
•
Publication
31028080 | J:349085
First Author: Fleet JC
Year: 2019
Journal: Cancer Prev Res (Phila)
Title: Vitamin D Signaling Suppresses Early Prostate Carcinogenesis in TgAPT(121) Mice.
Volume: 12
Issue: 6
Pages: 343-356
•
•
•
•
•
Publication
27300434 | J:232329
First Author: Zanconato F
Year: 2016
Journal: Cancer Cell
Title: YAP/TAZ at the Roots of Cancer.
Volume: 29
Issue: 6
Pages: 783-803
•
•
•
•
•
Publication
33186519 | J:300350
First Author: Guccini I
Year: 2021
Journal: Cancer Cell
Title: Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis.
Volume: 39
Issue: 1
Pages: 68-82.e9
•
•
•
•
•
Publication
36928314 | J:352792
 
First Author: Wang ME
Year: 2023
Journal: J Clin Invest
Title: RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis.
Volume: 133
Issue: 10
•
•
•
•
•
Publication
16400032 | J:104437
First Author: Cecena G
Year: 2006
Journal: Am J Pathol
Title: Differential sensitivity of mouse epithelial tissues to the polyomavirus middle T oncogene.
Volume: 168
Issue: 1
Pages: 310-20
•
•
•
•
•
Publication
27102301 | J:314542
First Author: Hafeez BB
Year: 2016
Journal: Oncotarget
Title: Tissue-specific conditional PKCε knockout mice: a model to precisely reveal PKCε functional role in initiation, promotion and progression of cancer.
Volume: 7
Issue: 22
Pages: 33069-80
•
•
•
•
•
Publication
29309058 | J:275855
First Author: Bezzi M
Year: 2018
Journal: Nat Med
Title: Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms.
Volume: 24
Issue: 2
Pages: 165-175
•
•
•
•
•
Publication
36088505 | J:330352
First Author: Ahn S
Year: 2022
Journal: Oncogene
Title: CXCR4 and CXCR7 signaling promotes tumor progression and obesity-associated epithelial-mesenchymal transition in prostate cancer cells.
Volume: 41
Issue: 41
Pages: 4633-4644
•
•
•
•
•
Publication
38453924 | J:345792
First Author: Cai H
Year: 2024
Journal: Nat Commun
Title: CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expression.
Volume: 15
Issue: 1
Pages: 2088
•
•
•
•
•
Publication
26206718 | J:224835
First Author: Belair CD
Year: 2015
Journal: EMBO Rep
Title: DGCR8 is essential for tumor progression following PTEN loss in the prostate.
Volume: 16
Issue: 9
Pages: 1219-32
•
•
•
•
•
Publication
31904290 | J:294657
First Author: Ruetten H
Year: 2020
Journal: Am J Physiol Renal Physiol
Title: Impact of sex, androgens, and prostate size on C57BL/6J mouse urinary physiology: urethral histology.
Volume: 318
Issue: 3
Pages: F617-F627
•
•
•
•
•
Publication
32701507 | J:302324
First Author: Li F
Year: 2020
Journal: J Clin Invest
Title: ERG orchestrates chromatin interactions to drive prostate cell fate reprogramming.
Volume: 130
Issue: 11
Pages: 5924-5941
•
•
•
•
•
Publication
14695195 | J:87067
First Author: Jin C
Year: 2003
Journal: Cancer Res
Title: Cooperation between ectopic FGFR1 and depression of FGFR2 in induction of prostatic intraepithelial neoplasia in the mouse prostate.
Volume: 63
Issue: 24
Pages: 8784-90
•
•
•
•
•
Genotype
Genotype
Symbol: Ctnnb1/Ctnnb1<+> Kras/Kras<+> Tg(Pbsn-cre)4Prb/?
Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Pten/Pten<+> Tg(ARR2/Pbsn-FGF8)3Prb/? Tg(Pbsn-cre)4Prb/?
Background: involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Pten/Pten Tg(CAG-fat-1)1Jxk/? Tg(Pbsn-cre)4Prb/?
Background: involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Hspa5/Hspa5 Pten/Pten Tg(Pbsn-cre)4Prb/?
Background: involves: 129 * 129S4/SvJae * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Hspa5/Hspa5 Pten/Pten Tg(Pbsn-cre)4Prb/?
Background: involves: 129 * 129S4/SvJae * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Hspa5/Hspa5<+> Pten/Pten Tg(Pbsn-cre)4Prb/?
Background: involves: 129 * 129S4/SvJae * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Pten/Pten Tg(Pbsn-cre)4Prb/?
Background: involves: 129S4/SvJae * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Pten/Pten Tg(Pbsn-cre)4Prb/?
Background: involves: 129S4/SvJae * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Pten/Pten Cop1/Cop1 Tg(Pbsn-cre)4Prb/?
Background: B6N.CgCop1 Pten Tg(Pbsn-cre)4Prb
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Ar/? Pten/Pten Tg(Pbsn-cre)4Prb/?
Background: involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Pten/Pten<+> Tg(Pbsn-cre)4Prb/?
Background: involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Pten/Pten Tert/Tert Trp53/Trp53 Tg(Pbsn-cre)4Prb/?
Background: involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Pten/Pten Tert/Tert<+> Trp53/Trp53 Tg(Pbsn-cre)4Prb/?
Background: involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Erg/Erg Pten/Pten Tmprss2/Tmprss2 Tg(Pbsn-cre)4Prb/?
Background: involves: 129S4/SvJae * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Pten/Pten<+> Tmprss2/Tmprss2 Tg(Pbsn-cre)4Prb/?
Background: involves: 129S4/SvJae * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Col1a1/Col1a1<+> Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Pbsn-cre)4Prb/?
Background: involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Kras/Kras<+> Pten/Pten Tg(Pbsn-cre)4Prb/?
Background: involves: 129S4/SvJae * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Kras/Kras<+> Pten/Pten<+> Tg(Pbsn-cre)4Prb/?
Background: involves: 129S4/SvJae * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Pten/Pten Tg(CAG-MYC,-GFP*)#Rugg/? Tg(Pbsn-cre)4Prb/?
Background: involves: 129S4/SvJae * C57BL/6 * C57BL/6J * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Eif2ak3/Eif2ak3 Pten/Pten Tg(CAG-MYC,-GFP*)#Rugg/? Tg(Pbsn-cre)4Prb/?
Background: involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Pten/Pten Ptpn1/Ptpn1 Tg(Pbsn-cre)4Prb/?
Background: involves: 129S4/SvJae * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Igs2/Igs2<+> Tg(Pbsn-cre)4Prb/?
Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2 * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Igs2/Igs2<+> Pten/Pten Tg(Pbsn-cre)4Prb/?
Background: involves: 129 * C57BL/6 * DBA/2 * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Ctnnb1/Ctnnb1<+> Igs2/Igs2<+> Tg(Pbsn-cre)4Prb/?
Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2 * FVB/N
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Pten/Pten Rb1/Rb1 Tg(Pbsn-cre)4Prb/?
Background: involves: 129 * 129S1/Sv * 129S6/SvEvTac * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Pten/Pten Rb1/Rb1<+> Tg(Pbsn-cre)4Prb/?
Background: involves: 129 * 129S1/Sv * 129S6/SvEvTac * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Pten/Pten Tg(Pbsn-cre)4Prb/?
Background: involves: 129 * 129S1/Sv * 129S6/SvEvTac * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Pbsn-cre)4Prb/?
Background: involves: 129S4/SvJaeSor * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Klf5/Klf5 Pten/Pten Tg(Pbsn-cre)4Prb/?
Background: involves: 129S4/SvJae * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Rb1/Rb1 Trp53/Trp53 Tg(Pbsn-cre)4Prb/?
Background: involves: 129 * 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Ext1/Ext1 Pten/Pten Tg(Pbsn-cre)4Prb/?
Background: involves: 129S4/SvJae * BALB/c * C57BL/6
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Publication
21620777 | J:172730
First Author: Mulholland DJ
Year: 2011
Journal: Cancer Cell
Title: Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth.
Volume: 19
Issue: 6
Pages: 792-804
•
•
•
•
•
Publication
24984151 | J:220146
First Author: Nair VS
Year: 2014
Journal: Biochem Biophys Res Commun
Title: Down-regulation of Tet2 prevents TSDR demethylation in IL2 deficient regulatory T cells.
Volume: 450
Issue: 1
Pages: 918-24
•
•
•
•
•
Publication
21187395 | J:169702
First Author: Sun H
Year: 2011
Journal: Proc Natl Acad Sci U S A
Title: E2f binding-deficient Rb1 protein suppresses prostate tumor progression in vivo.
Volume: 108
Issue: 2
Pages: 704-9
•
•
•
•
•
Publication
17047082 | J:114992
First Author: Mao J
Year: 2006
Journal: Cancer Res
Title: A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway.
Volume: 66
Issue: 20
Pages: 10171-8
•
•
•
•
•
Publication
15885713 | J:100619
First Author: Klein RD
Year: 2005
Journal: Mutat Res
Title: The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research.
Volume: 576
Issue: 1-2
Pages: 111-9
•
•
•
•
•
Publication
32089544 | J:297768
First Author: He Y
Year: 2020
Journal: Oncogene
Title: Androgen receptor with short polyglutamine tract preferably enhances Wnt/β-catenin-mediated prostatic tumorigenesis.
Volume: 39
Issue: 16
Pages: 3276-3291
•
•
•
•
•
Publication
31719098 | J:284074
First Author: Patel R
Year: 2020
Journal: Cancer Res
Title: Activation of β-Catenin Cooperates with Loss of Pten to Drive AR-Independent Castration-Resistant Prostate Cancer.
Volume: 80
Issue: 3
Pages: 576-590
•
•
•
•
•
Publication
17607361 | J:124208
First Author: Berquin IM
Year: 2007
Journal: J Clin Invest
Title: Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids.
Volume: 117
Issue: 7
Pages: 1866-75
•
•
•
•
•
Publication
21624358 | J:175387
First Author: Wu X
Year: 2011
Journal: Dev Biol
Title: Differentiation of the ductal epithelium and smooth muscle in the prostate gland are regulated by the Notch/PTEN-dependent mechanism.
Volume: 356
Issue: 2
Pages: 337-49
•
•
•
•
•
Publication
18245377 | J:131932
First Author: Klezovitch O
Year: 2008
Journal: Proc Natl Acad Sci U S A
Title: A causal role for ERG in neoplastic transformation of prostate epithelium.
Volume: 105
Issue: 6
Pages: 2105-10
•
•
•
•
•
Publication
29844131 | J:286345
First Author: Blee AM
Year: 2018
Journal: Clin Cancer Res
Title: TMPRSS2-ERG Controls Luminal Epithelial Lineage and Antiandrogen Sensitivity in PTEN and TP53-Mutated Prostate Cancer.
Volume: 24
Issue: 18
Pages: 4551-4565
•
•
•
•
•
Publication
28321130 | J:243873
First Author: Lu X
Year: 2017
Journal: Nature
Title: Effective combinatorial immunotherapy for castration-resistant prostate cancer.
Volume: 543
Issue: 7647
Pages: 728-732
•
•
•
•
•
Publication
39024561 | J:353584
 
First Author: Ku SY
Year: 2024
Journal: J Clin Invest
Title: Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer.
Volume: 134
Issue: 17
•
•
•
•
•
Publication
21685943 | J:181074
First Author: Kim J
Year: 2012
Journal: Oncogene
Title: A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53.
Volume: 31
Issue: 3
Pages: 322-32
•
•
•
•
•
Publication
28059767 | J:237907
First Author: Ku SY
Year: 2017
Journal: Science
Title: Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance.
Volume: 355
Issue: 6320
Pages: 78-83
•
•
•
•
•
Publication
34301759 | J:312348
First Author: El-Kenawi A
Year: 2021
Journal: Cancer Res
Title: Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer.
Volume: 81
Issue: 21
Pages: 5477-5490
•
•
•
•
•
Publication
17671224 | J:123911
First Author: Liao CP
Year: 2007
Journal: Cancer Res
Title: Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence.
Volume: 67
Issue: 15
Pages: 7525-33
•
•
•
•
•
Publication
39303726 | J:357411
First Author: Calì B
Year: 2024
Journal: Cancer Cell
Title: Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer.
Volume: 42
Issue: 10
Pages: 1676-1692.e11
•
•
•
•
•
Publication
25056937 | J:317519
First Author: Nazarian A
Year: 2014
Journal: Mol Cell Proteomics
Title: Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer.
Volume: 13
Issue: 11
Pages: 3082-96
•
•
•
•
•
Publication
19185849 | J:144810
First Author: Guertin DA
Year: 2009
Journal: Cancer Cell
Title: mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice.
Volume: 15
Issue: 2
Pages: 148-59
•
•
•
•
•
Publication
25298407 | J:219675
First Author: Bianchi-Frias D
Year: 2015
Journal: Mol Cancer Res
Title: The landscape of somatic chromosomal copy number aberrations in GEM models of prostate carcinoma.
Volume: 13
Issue: 2
Pages: 339-47
•
•
•
•
•
Publication
26477312 | J:226088
First Author: Manda KR
Year: 2016
Journal: Oncogene
Title: NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence.
Volume: 35
Issue: 25
Pages: 3282-92
•
•
•
•
•
Publication
30930119 | J:274194
First Author: Augello MA
Year: 2019
Journal: Cancer Cell
Title: CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis.
Volume: 35
Issue: 4
Pages: 603-617.e8
•
•
•
•
•
Publication
27357679 | J:234403
First Author: Ahmad I
Year: 2016
Journal: Proc Natl Acad Sci U S A
Title: Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer.
Volume: 113
Issue: 29
Pages: 8290-5
•
•
•
•
•
Publication
31658259 | J:280691
First Author: Olson A
Year: 2019
Journal: PLoS Genet
Title: The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression.
Volume: 15
Issue: 10
Pages: e1008451
•
•
•
•
•
Publication
23633519 | J:200095
First Author: Gu Z
Year: 2013
Journal: Carcinogenesis
Title: Polyunsaturated fatty acids affect the localization and signaling of PIP3/AKT in prostate cancer cells.
Volume: 34
Issue: 9
Pages: 1968-75
•
•
•
•
•
Publication
25502566 | J:222654
First Author: Palian BM
Year: 2014
Journal: PLoS Genet
Title: Maf1 is a novel target of PTEN and PI3K signaling that negatively regulates oncogenesis and lipid metabolism.
Volume: 10
Issue: 12
Pages: e1004789
•
•
•
•
•
Publication
19578399 | J:151623
First Author: Kim J
Year: 2009
Journal: PLoS Genet
Title: Interactions between cells with distinct mutations in c-MYC and Pten in prostate cancer.
Volume: 5
Issue: 7
Pages: e1000542
•
•
•
•
•
Publication
21572435 | J:172653
First Author: Vitari AC
Year: 2011
Journal: Nature
Title: COP1 is a tumour suppressor that causes degradation of ETS transcription factors.
Volume: 474
Issue: 7351
Pages: 403-6
•
•
•
•
•
Publication
36991255 | J:344813
First Author: Tibbo AJ
Year: 2023
Journal: Br J Cancer
Title: MBTPS2 acts as a regulator of lipogenesis and cholesterol synthesis through SREBP signalling in prostate cancer.
Volume: 128
Issue: 11
Pages: 1991-1999
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom